1. FDA. Docket No. FDA-2021-D-0789: Diversity plans to improve enrollment of participants from underrepresented racial and ethnic subgroups in clinical trials; Draft Guidance for Industry. April 2022.
2. Drug Trials;David,2022
3. Office of Management and Budget, OMB-2023-0001-0001. Initial Proposals for Updating Race and Ethnicity Statistical Standards. Federal Register Number2023-01635. Jan 27, 2023: https://www.regulations.gov/document/OMB-2023-0001-0001
4. Lack of Arab or Middle Eastern and North African health data undermines assessment of health disparities;Awad;Am J Public Health.,2022
5. Epidemiology of type 2 diabetes in the Middle East and North Africa: challenges and call for action;El-Kebbi;World J Diabetes,2021